منابع مشابه
Big science, little science.
In the USA, where I live and work, it is well known that I have little love for structural genomics—the attempt to determine the structures of most or all of the proteins in an organism by some combination of high-throughput X-ray crystallo graphy, nuclear magnetic resonance spectroscopy and homology modelling. My reasons are a matter of public record: structural genomics is based on an assumpt...
متن کاملBig Pharma, little science? A bibliometric perspective on big pharma's R&D decline
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing R&D costs. This study explores pharmaceutical R&D dynamics by examining the publication activities of all R&D laboratories of the major European and US pharmaceutical firms during the period 1995-2009. The empirical f...
متن کاملComment on 'Big science, little science'.
upfront cor respondence conference in New York on the demographic problem of the Jews excluded Jews. Israeli universities and research institutions are thus not independent of the Israeli State and its political agendas and acts. Rather, they, and many of the academics within them, are active creators and endors-ers. As I emphasised in my Opinion column, a boycott is a tactic, not an end in its...
متن کاملBig Pharma (The Play)
A nyone who has experienced the assault of the pharmaceutical industry's marketing campaigns would appreciate Jennifer Berry's one-person play Big Pharma: The Rise of the Anti-Depressant Drug Industry and the Loss of a Generation. Since the mid-1990s, spending on drug promotion has grown steadily, reaching $21 billion in 2002. Berry explores the fallout of this expanded marketing blitz through ...
متن کاملBypassing big pharma.
There have been many resounding victories in the war against coronary artery disease. Among those are antiarrhythmic drugs, pacemakers, coronary bypass surgery, coronary angioplasty, reperfusion therapy, and statins. But the one goal that has continuously eluded us has been the clinical availability of an effective cardioprotective agent. Although reperfusion therapy has partially achieved the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Technological Forecasting and Social Change
سال: 2014
ISSN: 0040-1625
DOI: 10.1016/j.techfore.2012.06.007